Selected research
Industry Research
Bioconjugation Industry Research Report 2026
Market perspective
The global Bioconjugation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bioconjugation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bioconjugation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bioconjugation include WuXi Biologics, Thermo Fisher Scientific, Merck, Roche, Lonza, AbbVie, Sartorius, Promega and Piramal Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bioconjugation market in terms of revenue (US$ million) and, where applicable, sales volume (Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bioconjugation Market by Company
WuXi Biologics
Thermo Fisher Scientific
Merck
Roche
Lonza
AbbVie
Sartorius
Promega
Piramal Pharma
Genscript Biotech
Danaher
Charles River Laboratories
Catalent
Bio-Rad Laboratories
BD
Agilent
Bioconjugation Segment by Type
Chemical Conjugation
Click Chemistry
Enzyme-mediated Conjugatio
Others
Bioconjugation Segment by Application
Pharmaceutical
Hosptial
Research Institutes
Others
Bioconjugation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bioconjugation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bioconjugation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bioconjugation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Chemical Conjugation
- Click Chemistry
- Enzyme-mediated Conjugatio
- Others
Applications
- Pharmaceutical
- Hosptial
- Research Institutes
- Others
Companies covered
- WuXi Biologics
- Thermo Fisher Scientific
- Merck
- Roche
- Lonza
- AbbVie
- Sartorius
- Promega
- Piramal Pharma
- Genscript Biotech
- Danaher
- Charles River Laboratories
- Catalent
- Bio-Rad Laboratories
- BD
- Agilent
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bioconjugation Market Size (2021-2032)
- 2.2.2 Global Bioconjugation Sales (2021-2032)
- 2.2.3 Global Bioconjugation Market Average Price (2021-2032)
- 2.3 Bioconjugation by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Chemical Conjugation
- 2.3.3 Click Chemistry
- 2.3.4 Enzyme-mediated Conjugatio
- 2.3.5 Others
- 2.4 Bioconjugation by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical
- 2.4.3 Hosptial
- 2.4.4 Research Institutes
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bioconjugation Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bioconjugation Sales (Units) of Manufacturers (2021-2026)
- 3.3 Global Bioconjugation Revenue of Manufacturers (2021-2026)
- 3.4 Global Bioconjugation Average Price by Manufacturers (2021-2026)
- 3.5 Global Bioconjugation Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bioconjugation, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bioconjugation, Product Type & Application
- 3.8 Global Manufacturers of Bioconjugation, Established Date
- 3.9 Global Bioconjugation Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 WuXi Biologics
- 4.1.1 WuXi Biologics Company Information
- 4.1.2 WuXi Biologics Business Overview
- 4.1.3 WuXi Biologics Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 WuXi Biologics Bioconjugation Product Portfolio
- 4.1.5 WuXi Biologics Recent Developments
- 4.2 Thermo Fisher Scientific
- 4.2.1 Thermo Fisher Scientific Company Information
- 4.2.2 Thermo Fisher Scientific Business Overview
- 4.2.3 Thermo Fisher Scientific Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Thermo Fisher Scientific Bioconjugation Product Portfolio
- 4.2.5 Thermo Fisher Scientific Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Bioconjugation Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Roche
- 4.4.1 Roche Company Information
- 4.4.2 Roche Business Overview
- 4.4.3 Roche Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Roche Bioconjugation Product Portfolio
- 4.4.5 Roche Recent Developments
- 4.5 Lonza
- 4.5.1 Lonza Company Information
- 4.5.2 Lonza Business Overview
- 4.5.3 Lonza Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lonza Bioconjugation Product Portfolio
- 4.5.5 Lonza Recent Developments
- 4.6 AbbVie
- 4.6.1 AbbVie Company Information
- 4.6.2 AbbVie Business Overview
- 4.6.3 AbbVie Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 AbbVie Bioconjugation Product Portfolio
- 4.6.5 AbbVie Recent Developments
- 4.7 Sartorius
- 4.7.1 Sartorius Company Information
- 4.7.2 Sartorius Business Overview
- 4.7.3 Sartorius Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sartorius Bioconjugation Product Portfolio
- 4.7.5 Sartorius Recent Developments
- 4.8 Promega
- 4.8.1 Promega Company Information
- 4.8.2 Promega Business Overview
- 4.8.3 Promega Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Promega Bioconjugation Product Portfolio
- 4.8.5 Promega Recent Developments
- 4.9 Piramal Pharma
- 4.9.1 Piramal Pharma Company Information
- 4.9.2 Piramal Pharma Business Overview
- 4.9.3 Piramal Pharma Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Piramal Pharma Bioconjugation Product Portfolio
- 4.9.5 Piramal Pharma Recent Developments
- 4.10 Genscript Biotech
- 4.10.1 Genscript Biotech Company Information
- 4.10.2 Genscript Biotech Business Overview
- 4.10.3 Genscript Biotech Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Genscript Biotech Bioconjugation Product Portfolio
- 4.10.5 Genscript Biotech Recent Developments
- 4.11 Danaher
- 4.11.1 Danaher Company Information
- 4.11.2 Danaher Business Overview
- 4.11.3 Danaher Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Danaher Bioconjugation Product Portfolio
- 4.11.5 Danaher Recent Developments
- 4.12 Charles River Laboratories
- 4.12.1 Charles River Laboratories Company Information
- 4.12.2 Charles River Laboratories Business Overview
- 4.12.3 Charles River Laboratories Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Charles River Laboratories Bioconjugation Product Portfolio
- 4.12.5 Charles River Laboratories Recent Developments
- 4.13 Catalent
- 4.13.1 Catalent Company Information
- 4.13.2 Catalent Business Overview
- 4.13.3 Catalent Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Catalent Bioconjugation Product Portfolio
- 4.13.5 Catalent Recent Developments
- 4.14 Bio-Rad Laboratories
- 4.14.1 Bio-Rad Laboratories Company Information
- 4.14.2 Bio-Rad Laboratories Business Overview
- 4.14.3 Bio-Rad Laboratories Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Bio-Rad Laboratories Bioconjugation Product Portfolio
- 4.14.5 Bio-Rad Laboratories Recent Developments
- 4.15 BD
- 4.15.1 BD Company Information
- 4.15.2 BD Business Overview
- 4.15.3 BD Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 BD Bioconjugation Product Portfolio
- 4.15.5 BD Recent Developments
- 4.16 Agilent
- 4.16.1 Agilent Company Information
- 4.16.2 Agilent Business Overview
- 4.16.3 Agilent Bioconjugation Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Agilent Bioconjugation Product Portfolio
- 4.16.5 Agilent Recent Developments
5 Global Bioconjugation Market Scenario by Region
- 5.1 Global Bioconjugation Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bioconjugation Sales by Region: 2021-2032
- 5.2.1 Global Bioconjugation Sales by Region: 2021-2026
- 5.2.2 Global Bioconjugation Sales by Region: 2027-2032
- 5.3 Global Bioconjugation Revenue by Region: 2021-2032
- 5.3.1 Global Bioconjugation Revenue by Region: 2021-2026
- 5.3.2 Global Bioconjugation Revenue by Region: 2027-2032
- 5.4 North America Bioconjugation Market Facts & Figures by Country
- 5.4.1 North America Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bioconjugation Sales by Country (2021-2032)
- 5.4.3 North America Bioconjugation Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bioconjugation Market Facts & Figures by Country
- 5.5.1 Europe Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bioconjugation Sales by Country (2021-2032)
- 5.5.3 Europe Bioconjugation Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bioconjugation Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bioconjugation Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bioconjugation Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bioconjugation Market Facts & Figures by Country
- 5.7.1 South America Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bioconjugation Sales by Country (2021-2032)
- 5.7.3 South America Bioconjugation Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bioconjugation Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bioconjugation Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bioconjugation Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bioconjugation Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bioconjugation Sales by Type (2021-2032)
- 6.1.1 Global Bioconjugation Sales by Type (2021-2032) & (Units)
- 6.1.2 Global Bioconjugation Sales Market Share by Type (2021-2032)
- 6.2 Global Bioconjugation Revenue by Type (2021-2032)
- 6.2.1 Global Bioconjugation Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bioconjugation Revenue Market Share by Type (2021-2032)
- 6.3 Global Bioconjugation Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bioconjugation Sales by Application (2021-2032)
- 7.1.1 Global Bioconjugation Sales by Application (2021-2032) & (Units)
- 7.1.2 Global Bioconjugation Sales Market Share by Application (2021-2032)
- 7.2 Global Bioconjugation Revenue by Application (2021-2032)
- 7.2.1 Global Bioconjugation Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bioconjugation Revenue Market Share by Application (2021-2032)
- 7.3 Global Bioconjugation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bioconjugation Value Chain Analysis
- 8.1.1 Bioconjugation Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bioconjugation Production Mode & Process
- 8.2 Bioconjugation Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bioconjugation Distributors
- 8.2.3 Bioconjugation Customers
9 Global Bioconjugation Analyzing Market Dynamics
- 9.1 Bioconjugation Industry Trends
- 9.2 Bioconjugation Industry Drivers
- 9.3 Bioconjugation Industry Opportunities and Challenges
- 9.4 Bioconjugation Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst